Literature DB >> 19005228

The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study.

Mireia Junyent1, Katherine L Tucker1, Caren E Smith1, Antonio Garcia-Rios1, Josiemer Mattei1, Chao-Qiang Lai1, Laurence D Parnell1, Jose M Ordovas2.   

Abstract

Low HDL-cholesterol (HDL-C) is associated with an increased risk for atherosclerosis, and concentrations are modulated by genetic factors and environmental factors such as smoking. Our objective was to assess whether the association of common single-nucleotide polymorphisms (SNPs) at ABCG5/G8 (i18429G>A, i7892T>C, Gln604GluC>G, 5U145A>C, Tyr54CysA>G, Asp19HisG>C, i14222A>G, and Thr400LysC>A) genes with HDL-C differs according to smoking habit. ABCG5/G8 SNPs were genotyped in 845 participants (243 men and 602 women). ABCG5/G8 (i7892T>C, 5U145A>C, Tyr54CysA>G, Thr400LysC>A) SNPs were significantly associated with HDL-C concentrations (P < 0.001-0.013) by which carriers of the minor alleles at the aforementioned polymorphisms and homozygotes for the Thr400 allele displayed lower HDL-C. A significant gene-smoking interaction was found, in which carriers of the minor alleles at ABCG5/G8 (Gln604GluC>G, Asp19HisG>C, i14222A>G) SNPs displayed lower concentrations of HDL-C only if they were smokers (P = 0.001-0.025). Also, for ABCG8_Thr400LysC>A SNP, smokers, but not nonsmokers, homozygous for the Thr400 allele displayed lower HDL-C (P = 0.004). Further analyses supported a significant haplotype global effect on lowering HDL-C (P = 0.002) among smokers. In conclusion, ABCG5/G8 genetic variants modulate HDL-C concentrations, leading to an HDL-C-lowering effect and thereby a potential increased risk for atherosclerosis only in smokers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005228      PMCID: PMC2638110          DOI: 10.1194/jlr.P800041-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  44 in total

1.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

Authors:  Daniel Falush; Matthew Stephens; Jonathan K Pritchard
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

2.  Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

Authors:  W Y Craig; G E Palomaki; J E Haddow
Journal:  BMJ       Date:  1989-03-25

3.  Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.

Authors:  J Wang; C Einarsson; C Murphy; P Parini; I Björkhem; M Gåfvels; G Eggertsen
Journal:  J Lipid Res       Date:  2005-11-01       Impact factor: 5.922

Review 4.  ATP-Binding cassette cholesterol transporters and cardiovascular disease.

Authors:  John F Oram; Ashley M Vaughan
Journal:  Circ Res       Date:  2006-11-10       Impact factor: 17.367

Review 5.  Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.

Authors:  Sara Chelland Campbell; Robert J Moffatt; Bryant A Stamford
Journal:  Atherosclerosis       Date:  2008-05-13       Impact factor: 5.162

6.  Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport.

Authors:  Agueda C M Zaratin; Eder C R Quintão; Andrei C Sposito; Valéria S Nunes; Ana Maria Lottenberg; Richard E Morton; Eliana C de Faria
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

7.  Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.

Authors:  Liqing Yu; Jia Li-Hawkins; Robert E Hammer; Knut E Berge; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey.

Authors:  Bin Zhang; Joe Menzin; Mark Friedman; Jonathan R Korn; Russel T Burge
Journal:  Curr Med Res Opin       Date:  2008-08-12       Impact factor: 2.580

9.  Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution.

Authors:  D J Freeman; B A Griffin; E Murray; G M Lindsay; D Gaffney; C J Packard; J Shepherd
Journal:  Eur J Clin Invest       Date:  1993-10       Impact factor: 4.686

10.  Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.

Authors:  Thomas P Beyer; Robert J Schmidt; Patricia Foxworthy; Youyan Zhang; Jiannong Dai; William R Bensch; Raymond F Kauffman; Hong Gao; Timothy P Ryan; Xian-Cheng Jiang; Sotirios K Karathanasis; Patrick I Eacho; Guoqing Cao
Journal:  J Pharmacol Exp Ther       Date:  2004-02-11       Impact factor: 4.030

View more
  22 in total

Review 1.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

2.  Genetic association with lipids in Filipinos: waist circumference modifies an APOA5 effect on triglyceride levels.

Authors:  Ying Wu; Amanda F Marvelle; Jin Li; Damien C Croteau-Chonka; Alan B Feranil; Christopher W Kuzawa; Yun Li; Linda S Adair; Karen L Mohlke
Journal:  J Lipid Res       Date:  2013-09-10       Impact factor: 5.922

Review 3.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

Review 4.  Metabolic syndrome components in murine models.

Authors:  Heather A Lawson; James M Cheverud
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-03       Impact factor: 2.895

Review 5.  The longitudinal association of vitamin D serum concentrations & adiposity phenotype.

Authors:  Aziza Jamal-Allial; John L Griffith; Katherine L Tucker
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-12       Impact factor: 4.292

6.  Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia.

Authors:  A Garcia-Rios; P Perez-Martinez; F Fuentes; P Mata; J Lopez-Miranda; R Alonso; F Rodriguez; A Garcia-Olid; J Ruano; J M Ordovas; F Perez-Jimenez
Journal:  Atherosclerosis       Date:  2010-01-22       Impact factor: 5.162

7.  The importance of context to the genetic architecture of diabetes-related traits is revealed in a genome-wide scan of a LG/J × SM/J murine model.

Authors:  Heather A Lawson; Arthur Lee; Gloria L Fawcett; Bing Wang; L Susan Pletscher; Taylor J Maxwell; Thomas H Ehrich; Jane P Kenney-Hunt; Jason B Wolf; Clay F Semenkovich; James M Cheverud
Journal:  Mamm Genome       Date:  2011-01-06       Impact factor: 2.957

8.  Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease.

Authors:  Zian H Tseng; Eric Vittinghoff; Stacy L Musone; Feng Lin; Dean Whiteman; Ludmila Pawlikowska; Pui-Yan Kwok; Jeffrey E Olgin; Bradley E Aouizerat
Journal:  Heart Rhythm       Date:  2009-08-28       Impact factor: 6.343

9.  The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health Study.

Authors:  M Junyent; K L Tucker; C E Smith; J M Lane; J Mattei; C Q Lai; L D Parnell; J M Ordovas
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-18       Impact factor: 4.222

10.  A composite scoring of genotypes discriminates coronary heart disease risk beyond conventional risk factors in the Boston Puerto Rican Health Study.

Authors:  M Junyent; K L Tucker; J Shen; Y-C Lee; C E Smith; J Mattei; C-Q Lai; L D Parnell; J M Ordovas
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-06-05       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.